---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-042903"
form_type: "8-K"
ticker: "VIVS"
cik: "0001497253"
company_name: "VivoSim Labs, INC."
filed_at: "2025-03-21T23:59:59+00:00"
generated_at: "2026-05-24T08:39:29.187433+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Organovo implements 1-for-12 reverse stock split to regain Nasdaq minimum bid price compliance

## Summary
- Reverse stock split at ratio 1-for-12, effective March 20, 2025, to combine every 12 shares into 1.
- Trading on Nasdaq Capital Market on split-adjusted basis begins March 21, 2025 under ticker ONVO.
- No fractional shares issued; cash paid in lieu based on March 19 closing price of common stock.
- Board approved reverse split ratio on March 6, 2025 after shareholder authorization granted November 20, 2024.
- Reverse split intended to cure Nasdaq minimum bid price deficiency for continued listing.

## SEC filing metadata
- accession: 0000950170-25-042903
- form_type: 8-K
- ticker: VIVS
- cik: 0001497253
- company_name: VivoSim Labs, INC.
- filed_at: 2025-03-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.03, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1497253/000095017025042903/0000950170-25-042903-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1497253/000095017025042903/onvo-20250320.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-042903
- JSON: https://secwatch.observer/filing/0000950170-25-042903.json
- Plain text: https://secwatch.observer/filing/0000950170-25-042903.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.